Rankings
▼
Calendar
ANIK FY 2017 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$208M
FY 2017 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$113M
+9.7% YoY
Gross Profit
$86M
75.9% margin
Operating Income
$46M
40.3% margin
Net Income
$32M
28.1% margin
EPS (Diluted)
$2.11
Cash Flow
Operating Cash Flow
$41M
Free Cash Flow
$32M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$283M
Total Liabilities
$19M
Stockholders' Equity
$263M
Cash & Equivalents
$133M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$113M
$103M
+9.7%
Gross Profit
$86M
$79M
+8.4%
Operating Income
$46M
$51M
-9.6%
Net Income
$32M
$33M
-2.2%
← Q4 2016
All Quarters
Q1 2017 →